vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Natural Grocers by Vitamin Cottage, Inc. (NGVC). Click either name above to swap in a different company.

Natural Grocers by Vitamin Cottage, Inc. is the larger business by last-quarter revenue ($335.6M vs $208.9M, roughly 1.6× iRhythm Holdings, Inc.). Natural Grocers by Vitamin Cottage, Inc. runs the higher net margin — 3.4% vs 2.7%, a 0.7% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 1.6%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $11.6M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 4.4%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

Natural Grocers by Vitamin Cottage, Inc. is a U.S.-based specialty retail chain that offers certified organic groceries, dietary supplements, natural personal care items, and eco-friendly household products. It serves health-conscious consumers across multiple U.S. states, following strict quality standards that exclude artificial preservatives, colors, flavors and harmful additives.

IRTC vs NGVC — Head-to-Head

Bigger by revenue
NGVC
NGVC
1.6× larger
NGVC
$335.6M
$208.9M
IRTC
Growing faster (revenue YoY)
IRTC
IRTC
+25.5% gap
IRTC
27.1%
1.6%
NGVC
Higher net margin
NGVC
NGVC
0.7% more per $
NGVC
3.4%
2.7%
IRTC
More free cash flow
IRTC
IRTC
$2.9M more FCF
IRTC
$14.5M
$11.6M
NGVC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
4.4%
NGVC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IRTC
IRTC
NGVC
NGVC
Revenue
$208.9M
$335.6M
Net Profit
$5.6M
$11.3M
Gross Margin
70.9%
29.5%
Operating Margin
1.1%
4.4%
Net Margin
2.7%
3.4%
Revenue YoY
27.1%
1.6%
Net Profit YoY
518.5%
14.0%
EPS (diluted)
$0.18
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
NGVC
NGVC
Q4 25
$208.9M
$335.6M
Q3 25
$192.9M
$336.1M
Q2 25
$186.7M
$328.7M
Q1 25
$158.7M
$335.8M
Q4 24
$164.3M
$330.2M
Q3 24
$147.5M
$322.7M
Q2 24
$148.0M
$309.1M
Q1 24
$131.9M
$308.1M
Net Profit
IRTC
IRTC
NGVC
NGVC
Q4 25
$5.6M
$11.3M
Q3 25
$-5.2M
$11.8M
Q2 25
$-14.2M
$11.6M
Q1 25
$-30.7M
$13.1M
Q4 24
$-1.3M
$9.9M
Q3 24
$-46.2M
$9.0M
Q2 24
$-20.1M
$9.2M
Q1 24
$-45.7M
$8.0M
Gross Margin
IRTC
IRTC
NGVC
NGVC
Q4 25
70.9%
29.5%
Q3 25
71.1%
29.5%
Q2 25
71.2%
29.9%
Q1 25
68.8%
30.3%
Q4 24
70.0%
29.9%
Q3 24
68.8%
29.6%
Q2 24
69.9%
29.2%
Q1 24
66.3%
29.3%
Operating Margin
IRTC
IRTC
NGVC
NGVC
Q4 25
1.1%
4.4%
Q3 25
-4.4%
4.6%
Q2 25
-10.0%
4.7%
Q1 25
-20.5%
5.2%
Q4 24
-2.5%
4.0%
Q3 24
-34.1%
3.7%
Q2 24
-15.5%
4.2%
Q1 24
-28.9%
3.7%
Net Margin
IRTC
IRTC
NGVC
NGVC
Q4 25
2.7%
3.4%
Q3 25
-2.7%
3.5%
Q2 25
-7.6%
3.5%
Q1 25
-19.3%
3.9%
Q4 24
-0.8%
3.0%
Q3 24
-31.3%
2.8%
Q2 24
-13.6%
3.0%
Q1 24
-34.6%
2.6%
EPS (diluted)
IRTC
IRTC
NGVC
NGVC
Q4 25
$0.18
$0.49
Q3 25
$-0.16
$0.51
Q2 25
$-0.44
$0.50
Q1 25
$-0.97
$0.56
Q4 24
$-0.03
$0.43
Q3 24
$-1.48
$0.38
Q2 24
$-0.65
$0.40
Q1 24
$-1.47
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
NGVC
NGVC
Cash + ST InvestmentsLiquidity on hand
$583.8M
$23.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$152.7M
$220.0M
Total Assets
$1.0B
$668.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
NGVC
NGVC
Q4 25
$583.8M
$23.2M
Q3 25
$565.2M
$17.1M
Q2 25
$545.5M
$13.2M
Q1 25
$520.6M
$21.2M
Q4 24
$535.6M
$6.3M
Q3 24
$522.0M
$8.9M
Q2 24
$561.5M
$13.9M
Q1 24
$569.1M
$11.0M
Stockholders' Equity
IRTC
IRTC
NGVC
NGVC
Q4 25
$152.7M
$220.0M
Q3 25
$121.9M
$212.4M
Q2 25
$103.7M
$202.5M
Q1 25
$86.7M
$193.0M
Q4 24
$90.9M
$181.9M
Q3 24
$71.8M
$174.3M
Q2 24
$99.2M
$167.8M
Q1 24
$90.3M
$160.0M
Total Assets
IRTC
IRTC
NGVC
NGVC
Q4 25
$1.0B
$668.6M
Q3 25
$995.2M
$670.5M
Q2 25
$964.0M
$659.0M
Q1 25
$926.1M
$664.6M
Q4 24
$931.4M
$648.9M
Q3 24
$909.7M
$655.5M
Q2 24
$919.2M
$654.4M
Q1 24
$909.8M
$656.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
NGVC
NGVC
Operating Cash FlowLast quarter
$26.2M
$21.1M
Free Cash FlowOCF − Capex
$14.5M
$11.6M
FCF MarginFCF / Revenue
6.9%
3.4%
Capex IntensityCapex / Revenue
5.6%
2.9%
Cash ConversionOCF / Net Profit
4.70×
1.86×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$42.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
NGVC
NGVC
Q4 25
$26.2M
$21.1M
Q3 25
$34.9M
$15.6M
Q2 25
$27.7M
$2.9M
Q1 25
$-7.9M
$34.1M
Q4 24
$19.2M
$2.7M
Q3 24
$24.3M
$24.5M
Q2 24
$11.8M
$12.4M
Q1 24
$-52.0M
$20.2M
Free Cash Flow
IRTC
IRTC
NGVC
NGVC
Q4 25
$14.5M
$11.6M
Q3 25
$20.1M
$7.5M
Q2 25
$17.3M
$-4.2M
Q1 25
$-17.3M
$27.6M
Q4 24
$12.4M
$-6.9M
Q3 24
$15.5M
$18.0M
Q2 24
$3.4M
$3.6M
Q1 24
$-61.8M
$9.8M
FCF Margin
IRTC
IRTC
NGVC
NGVC
Q4 25
6.9%
3.4%
Q3 25
10.4%
2.2%
Q2 25
9.3%
-1.3%
Q1 25
-10.9%
8.2%
Q4 24
7.5%
-2.1%
Q3 24
10.5%
5.6%
Q2 24
2.3%
1.2%
Q1 24
-46.8%
3.2%
Capex Intensity
IRTC
IRTC
NGVC
NGVC
Q4 25
5.6%
2.9%
Q3 25
7.7%
2.4%
Q2 25
5.6%
2.2%
Q1 25
5.9%
1.9%
Q4 24
4.2%
2.9%
Q3 24
6.0%
2.0%
Q2 24
5.7%
2.9%
Q1 24
7.4%
3.4%
Cash Conversion
IRTC
IRTC
NGVC
NGVC
Q4 25
4.70×
1.86×
Q3 25
1.32×
Q2 25
0.25×
Q1 25
2.60×
Q4 24
0.27×
Q3 24
2.72×
Q2 24
1.35×
Q1 24
2.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

NGVC
NGVC

Grocery$243.8M73%
Dietary Supplements$60.7M18%
Manufactured Product Other$31.0M9%

Related Comparisons